抗病毒药物耐药性市场策略、顶级参与者、增长机会、2031 年分析和预测

  • Report Code : TIPRE00006395
  • Category : Life Sciences
  • No. of Pages : 150
立即购买

抗病毒药物耐药性市场规模预计将从 2023 年的 34.4 亿美元增至 2031 年的 63.5 亿美元。预计 2023-2031 年期间该市场的复合年增长率将达到 7.9%。肝病发病率上升、艾滋病毒和艾滋病的流行以及新兴国家对高质量产品的需求可能仍是市场的主要趋势。

抗病毒药物耐药性市场分析

近年来,全球范围内的 HIV/AIDS 发病率不断上升。获得性免疫缺陷综合征 (AIDS) 是一种慢性、可能危及生命的疾病,由人类免疫缺陷病毒 (HIV) 引起。该病毒会破坏免疫系统,HIV 会干扰人体对抗致病生物的能力。当 HIV 进入人体后,它会在一个月内出现类似流感的疾病。这种疾病被称为原发性或急性 HIV 感染,可能持续数周。根据美国卫生与公众服务部提供的数据以及部长的少数族裔艾滋病倡议基金 (SMAIF) 的支持,2022 年,全球约有 3900 万人感染 HIV/AIDS。绝大多数 HIV 感染者生活在中低收入国家。例如,根据印度 2017 年 HIV 估计报告(国家信息中心),在印度,HIV 的流行率估计为 0.22%(0.16%–0.30%)。此外,男性成人艾滋病毒感染率估计为 0.25%(0.18%-0.34%),女性成人艾滋病毒感染率估计为 0.19%(0.14-0.25%)。因此,预计该国的病毒感染病例将在预测期内推动对抗病毒药物耐药性市场的需求

抗病毒药物耐药性市场概况

多年来,肝炎发病率的上升和艾滋病毒/艾滋病患病率的上升推动了市场的增长。此外,新兴市场的增长可能会在预测期内对市场需求产生积极影响。然而,市场的增长受到替代方法等因素的制约。近年来,美国的艾滋病毒患病率有所上升。根据美国卫生与公众服务部提供的数据以及部长的少数民族艾滋病倡议基金 (SMAIF) 的支持,2021 年有近 32,100 名美国人新感染了艾滋病毒。因此,预计上述因素将在预测期内推动北美抗病毒药物耐药性市场的增长。

定制此报告以满足您的需求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

抗病毒药物耐药性市场:

Antiviral Drug Resistance Market
  • 获取此报告的关键市场趋势。
    这个免费样品将包括数据分析,从市场趋势到估计和预测。

抗病毒药物耐药性市场驱动因素和机遇

肝病发病率上升利好市场

病毒是可引起多种传染病(如流感、普通感冒和疣)的微小细菌。病毒还会引起严重疾病,包括天花、艾滋病毒/艾滋病和埃博拉病毒。病毒在细胞内繁殖,能够进入任何活的、健康的细胞,并繁殖和产生其他类似病毒。不同的病毒会攻击体内的特定细胞,如肝脏、大脑、皮肤、血液以及生殖系统、呼吸系统和胃肠系统。近年来,全球范围内肝炎等病毒感染的患病率有所增加。肝炎会导致肝脏损伤和炎症,还会损害其他器官。这是一个全球性的主要健康问题,可导致慢性感染,还会增加死于肝硬化和肝癌的风险。肝炎可分为甲型肝炎、乙型肝炎、丙型肝炎、丁型肝炎和戊型肝炎,它们通过不同的原因传播。据世界卫生组织统计,非洲和西太平洋区域是乙肝发病率最高的区域,这两个区域的成年人口感染率分别达到6.1%和6.2%。

新兴市场医疗支出不断增加

亚太地区、南美洲和中美洲等新兴经济体的医疗支出不断增加,这使得研究人员能够利用 PCR(聚合酶链反应)、下一代测序等先进技术开发多种病毒性疾病的治疗方案。美国国家癌症研究所 (NCI) 等多个组织为 HIV 和艾滋病恶性肿瘤研究提供资金,以研究在慢性 HIV 感染的情况下衰老如何影响癌症的风险、范围和生物学。中国、日本、巴西和其他新兴国家正在大量投入医疗支出,以确立其在市场上的地位,并确保各自国家的医院和研究机构、病理实验室和其他地点使用的仪器和试剂得到适当使用。

抗病毒药物耐药性市场报告细分分析

有助于得出抗病毒药物耐药性市场分析的关键部分是类型、疾病指征、技术和最终用户。

  • 根据类型,抗病毒药物耐药性市场分为试剂盒和试剂和仪器。试剂盒和试剂部分在 2023 年占据了最大的市场份额。
  • 根据疾病类型,市场分为 HIV、肝炎和巨细胞病毒 (CMV)。HIV 领域在 2023 年占据了最大的市场份额。
  • 从技术角度来看,市场细分为免疫诊断、聚合酶链反应 (PCR)、下一代测序 (NGS) 等。2023 年,免疫诊断领域占据了相当大的市场份额。
  • 根据最终用户,抗病毒药物耐药性市场分为医院和诊所、病理学或诊断实验室和研究机构。医院和诊所部分在 2023 年占据了最大的市场份额。

抗病毒药物耐药性市场份额(按地区)分析

抗病毒药物耐药性市场报告的地理范围主要分为五个区域:北美、亚太地区、欧洲、中东和非洲以及南美和中美。按地区划分,北美在高流量鼻插管市场中占有最大的市场份额。由于艾滋病毒和肝炎等病毒感染的流行、国家计划的存在以及政府机构的资助等各种因素,预计预测期内市场需求将大幅增长。近年来,美国的艾滋病毒流行率有所上升。根据美国卫生与公众服务部提供并得到部长少数民族艾滋病倡议基金 (SMAIF) 支持的数据,2021 年有近 32,100 名美国人新感染艾滋病毒。预计未来几年亚太地区将以最高的复合年增长率增长。

 

抗病毒药物耐药性市场区域洞察

Insight Partners 的分析师已详细解释了预测期内影响抗病毒药物耐药性市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的抗病毒药物耐药性市场细分和地理位置。

Antiviral Drug Resistance Market
  • 获取抗病毒药物耐药性市场的区域特定数据

抗病毒药物耐药性市场报告范围

报告属性细节
2023 年的市场规模34.4 亿美元
2031 年市场规模63.5亿美元
全球复合年增长率(2023 - 2031)7.9%
史料2021-2022
预测期2024-2031
涵盖的领域按产品
  • 试剂盒和试剂
  • 仪器
按疾病指征
  • 人类免疫缺陷病毒
  • 肝炎
  • 巨细胞病毒
按技术分类
  • 免疫诊断
  • 聚合酶链式反应
  • 下一代测序
  • 其他技术
按最终用户
  • 医院和诊所
  • 病理学或诊断实验室
  • 研究机构
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • AccuBioTech 有限公司;
  • ACON 实验室公司;
  • 西门子股份公司;
  • 生物梅里埃公司;
  • Bio-Rad 实验室公司;
  • 丹纳赫;
  • 雅培;
  • 屋宇署;
  • F 霍夫曼-罗氏有限公司;
  • 三一生物科技

 

抗病毒药物耐药性市场参与者密度:了解其对业务动态的影响

抗病毒药物耐药性市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。

市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。

在抗病毒药物耐药性市场运营的主要公司有:

  1. AccuBioTech 有限公司;
  2. ACON 实验室公司;
  3. 西门子股份公司;
  4. 生物梅里埃公司;
  5. Bio-Rad 实验室公司;
  6. 丹纳赫;

免责声明上面列出的公司没有按照任何特定顺序排列。


Antiviral Drug Resistance Market

 

  • 了解抗病毒药物耐药性市场顶级关键参与者概况

抗病毒药物耐药性市场新闻和最新发展

抗病毒药物耐药性市场通过收集来自一级和二级研究的定性和定量数据进行评估,其中包括重要的公司出版物、协会数据和数据库。以下列出了抗病毒药物耐药性市场的一些发展情况:

  • – 强生公司旗下的杨森制药公司(Janssen)今天宣布在《自然》杂志上发表新数据,表明一种早期临床候选药物(JNJ-1802)可为非人类灵长类动物和小鼠提供针对登革热的强效保护。这种首创抗病毒药物在 1 期首次人体临床研究中被证明是安全且耐受性良好的,目前正在进入 2 期临床研究,用于预防和治疗登革热。(来源:强生公司,新闻稿,2023 年 3 月)
  • Cipla Limited 宣布,该公司已获得印度药品管理总局 (DCGI) 的紧急使用授权 (EUA),可在该国推出 Molnupiravir。Cipla 计划以 Cipmolnu® 品牌推出 Molnupiravir。Molnupiravir 是英国药品和保健产品管理局 (MHRA) 批准的首个口服抗病毒药物,用于治疗有发展为重症风险的轻度至中度 COVID-19 患者。(来源:Cipla,新闻稿,2021 年 5 月)

抗病毒药物耐药性市场报告范围和交付成果

“抗病毒药物耐药性市场规模和预测(2021-2031)”报告对以下领域进行了详细的市场分析:

  • 抗病毒药物耐药性市场规模及预测,涵盖范围涵盖的所有主要细分市场的全球、区域和国家层面
  • 抗病毒药物耐药性市场趋势,以及驱动因素、限制因素和关键机遇等市场动态
  • 详细的 PEST/波特五力分析和 SWOT 分析
  • 抗病毒药物耐药性市场分析涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新市场发展
  • 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者以及抗病毒药物耐药性市场的最新发展
  • 详细的公司简介
  • 历史分析(2 年)、基准年、预测(7 年)及复合年增长率
  • PEST 和 SWOT 分析
  • 市场规模价值/数量 - 全球、区域、国家
  • 行业和竞争格局
  • Excel 数据集
antiviral-drug-resistance-market-report-deliverables-img1
antiviral-drug-resistance-market-report-deliverables-img2
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

常见问题


Which region dominated the Antiviral Drug Resistance market in 2023?

Based on geography, the antiviral drug resistance market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). North America is the largest contributor to the growth of the global antiviral drug resistance market. Asia Pacific is expected to register the highest CAGR in the antiviral drug resistance market during 2023–2031

What are the driving factors impacting the Antiviral Drug Resistance market?

Risisng in the incidences of hepatitis diseases followed by increasing prevalence of HIV and AIDS largely drive the antiviral drug resistance market size

Which are the leading players operating in the Antiviral Drug Resistance market?

The Antiviral Drug Resistance market majorly consists of players such AccuBioTech Co., Ltd.; ACON Laboratories, Inc.; Siemens AG; BioMérieux SA; Bio-Rad Laboratories, Inc.; Danaher; Abbott; BDF. Hoffmann-La Roche Ltd.; and Trinity Biotech.

What would be the estimated value of the Antiviral Drug Resistance market by 2031?

The antiviral drug resistance market size is projected to reach US$ 6.35 billion by 2031

What is the expected CAGR of the Antiviral Drug Resistance market?

The market is expected to register a CAGR of 7.9% during 2023–2031

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

antiviral-drug-resistance-market-cagr

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.